References
Attridge J. Innovation models and their application to the pharmaceutical sector. 2006; discussion paper 2: 1–19 [online]. Available from URL: http://www3.imperial.ac.uk/portal/pls/portallive/docs/1/7290711.PDF [Accessed 2009 Nov 27]
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. History and future of ICH [online]. Available from URL: http://www.ich.org/cache/compo/276-254-1.html [Accessed 2009 Nov 27]
Hunter AJ. The innovative medicines initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patients. Drug Discov Today 2008; 13: 371–3
United States Food and Drug Administration. FDA critical path initiative announcement [online]. Available from URL: http://www.trialstransformation.org/fda-critical-path-initiative-press-release/ [Accessed 2009 Nov 27]
Siva N. The drug price is right: or is it? Lancet 2009; 373: 1326–7
Eichler HG. Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma. Nat Rev Drug Discov 2008; 7: 818–26
Breckenridge A, Walley T. Early access to medicines. Clin Pharm Ther 2008; 84: 23–5
Strom BL. How the US drug safety system should be changed. JAMA 2006; 295: 2072–5
Lucas F, Easley C. A focus on commercial innovation and risk sharing. Axiom Dig 2009; 9–11 [online]. Available from URL: http://www.popewoodhead.com/downloads/Axiom_Digest_09.pdf [Accessed 2009 Nov 27]
Acknowledgements
This article benefited from the review of Dr Mel Walker, GlaxoSmithKline. The authors also acknowledge the inclusion of concepts presented by Dr Eric Abadie, Committee for Medicinal Products for Human Use at the European Medicines Agency; Dr Hilary Malone, Wyeth Laboratories; Clare McGrath, Pfizer Laboratories; Professor Robert Peterson, University of British Columbia; and Dr Ad Shuurman, Medicine Evaluation Committee at the workshop entitled “Review and reimburse-ment: a special case for better co-operation” held 29–30 September 2009, Surrey, UK, and sponsored by the Institute (http://www.cmr.org
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liberti, L.E., Pichler, F. & Walker, S.R. Preparing for Regulatory Review and Reimbursement Decisions. Pharm Med 23, 263–267 (2009). https://doi.org/10.1007/BF03256778
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03256778